Click to read this study in The Lancet Oncology.
#VisualAbstract: Carfilzomib, Dexamethasone, and Lenalidomide Superior to Lenalidomide Monotherapy for Multiple Myeloma
Apr 07, 2023
Advertisement
Business of Medicine
Advertisement
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.